Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

To see complete record on, please visit this link

Id: NCT01535937

Organisation Name: New York State Psychiatric Institute

Overal Status: Terminated

Start Date: February 2012

Last Update: May 1, 2019

Lead Sponsor: New York State Psychiatric Institute

Brief Summary: This project will evaluate the effect of a single sub-anesthetic dose of ketamine on the time to first cocaine use and abstinence rates in 60 treatment-seeking cocaine-dependent individuals receiving mindfulness-based relapse prevention (MBRP) therapy, using a 5 week combined laboratory-inpatient and outpatient double-blind, randomized, controlled trial.

  • Cocaine Dependence

Total execution time in seconds: 0.319580078125